Core Laboratories Inc. /DE/
Close on Oct 19, 2026
- Market cap
- $475.81M
- P/E (TTM)
- 19.5
- Dividend yield
- 0.39%
About Core Laboratories
Oil & Gas Field Services, NEC, SIC 1389
Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry. The company operates through two segments: Reservoir Description and Production Enhancement. Its Reservoir Description segment characterizes petroleum reservoir rock and fluid samples to help clients evaluate reservoir performance and increase recovery, while also supporting energy transition projects such as carbon capture and geothermal initiatives. The Production Enhancement segment offers perforating products, diagnostic services, and well completion solutions to optimize well stimulation and field development. The company serves major, national, and independent oil companies, as well as universities and research facilities.
The company operates facilities and offices across more than 50 countries, with non-U.S. operations spanning regions including Europe, Africa, the Middle East, Asia Pacific, Canada, Latin America, and the Former Soviet Union. Its global network consists of more than 70 offices and approximately 3,300 employees, with manufacturing primarily conducted in four facilities across the United States and Canada. Core Laboratories Inc. is incorporated in Delaware, though its specific headquarters location is not stated in the text.
Summary of the business section of Core Laboratories's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Core Laboratories Inc. /DE/
- Founded
- 1936
- Headquarters
- Houston, TX
- Address
- 6316 Windfern Road 77040
- Phone
- (713) 328-2673
- Employees
- 3,300, Dec 31, 2025
- Industry
- Oil & Gas Field Services, NEC
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- KPMG LLP, Houston, TX
Stock & identifiers
- Ticker
- CLB
- Exchange
- NYSE
- Shares outstanding
- 46M, Jul 24, 2026
- Public float
- $498.91M, Jun 30, 2025
- Filer category
- Large accelerated filer
- Stock splits
- 2-for-1, Jul 9, 2010; 2-for-1, Dec 22, 1997
- SEC CIK
- 1958086
- CUSIP
- 21867A105
- ISIN
- US21867A1051
- LEI
- 984500040P5J07V43135
- EIN
- 00-0000000
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Lawrence Bruno | Chairman and CEO, Director | 262,438 |
| Sow Hang Teo | CAO & Treasurer | 8,625 |
| Mark Damian Tattoli | SVP, Gen Counsel & Secretary | 29,478 |
| Gwendolyn Gresham | SVP | 33,226 |
| Christopher Scott Hill | SVP & CFO | 110,261 |
| Katherine Murray | Director | 29,290 |
| Curt Anastasio | Director | 23,805 |
| Robert F. Martinovich | Director | 8,069 |
| Martha Z. Carnes | Director | 54,397 |
| Harvey Robert Klingensmith | Director | 50,031 |
| Kwaku Temeng | Director | 33,597 |
| Michael Straughen | Director | 24,552 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 Mr. Bruno | $4.98M | $3.32M | $1.38M | $61 | $181 |
| FY2024 First Ceo | $7.93M | $6.50M | $1.64M | $47 | $101 |
| FY2024 Mr. Bruno | $5.72M | $6.50M | $1.64M | $47 | $101 |
| FY2024 Second Ceo | $0 | $0 | $1.64M | $47 | $101 |
| FY2023 First Ceo | $7.99M | $3.87M | $1.94M | $48 | $113 |
| FY2023 Mr. Bruno | $7.99M | $3.87M | $1.94M | $48 | $113 |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Employees
Headcount reported in annual reports
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Mar 3, 2026 | Late filing | Notification of late filing |
| Feb 28, 2023 | Name change | Name changed from Core Laboratories Luxembourg S.A. to Core Laboratories Inc. /DE/ |
| Jan 17, 2023 | Merger | Registration of securities for a merger or exchange offer (S-4) |